These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37000398)

  • 1. A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users.
    Bavato F; Kexel AK; Kluwe-Schiavon B; Maceski A; Baumgartner MR; Seifritz E; Kuhle J; Quednow BB
    Mol Neurobiol; 2023 Jul; 60(7):3935-3944. PubMed ID: 37000398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
    Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ
    Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study.
    Truffi M; Garofalo M; Ricciardi A; Cotta Ramusino M; Perini G; Scaranzin S; Gastaldi M; Albasini S; Costa A; Chiavetta V; Corsi F; Morasso C; Gagliardi S
    Sci Rep; 2023 Mar; 13(1):4041. PubMed ID: 36899015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.
    Kammeyer R; Mizenko C; Sillau S; Richie A; Owens G; Nair KV; Alvarez E; Vollmer TL; Bennett JL; Piquet AL
    Front Neurol; 2022; 13():689975. PubMed ID: 35309573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain as outcome marker for intensive care unit patients.
    Fisse AL; Pitarokoili K; Leppert D; Motte J; Pedreiturria X; Kappos L; Gold R; Kuhle J; Yoon MS
    J Neurol; 2021 Apr; 268(4):1323-1329. PubMed ID: 33098034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus.
    Margraf NG; Dargvainiene J; Theel E; Leypoldt F; Lieb W; Franke A; Berger K; Kuhle J; Kuhlenbaeumer G
    J Neurol; 2023 Apr; 270(4):2128-2138. PubMed ID: 36624182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neurofilament light chain levels predict improvement in late phase after stroke.
    Stokowska A; Bunketorp Käll L; Blomstrand C; Simrén J; Nilsson M; Zetterberg H; Blennow K; Pekny M; Pekna M
    Eur J Neurol; 2021 Jul; 28(7):2218-2228. PubMed ID: 33811783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
    Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
    J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
    Ashton NJ; Leuzy A; Lim YM; Troakes C; Hortobágyi T; Höglund K; Aarsland D; Lovestone S; Schöll M; Blennow K; Zetterberg H; Hye A
    Acta Neuropathol Commun; 2019 Jan; 7(1):5. PubMed ID: 30626432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament light chain as novel blood biomarker of disturbed neuroaxonal integrity in patients with ketamine dependence.
    Liu YL; Bavato F; Chung AN; Liu TH; Chen YL; Huang MC; Quednow BB
    World J Biol Psychiatry; 2021 Nov; 22(9):713-721. PubMed ID: 33783299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes.
    Ygland Rödström E; Mattsson-Carlgren N; Janelidze S; Hansson O; Puschmann A
    J Parkinsons Dis; 2022; 12(2):571-584. PubMed ID: 34806619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neurofilament light chain as a potential biomarker in Charcot-Marie-Tooth disease.
    Millere E; Rots D; Simrén J; Ashton NJ; Kupats E; Micule I; Priedite V; Kurjane N; Blennow K; Gailite L; Zetterberg H; Kenina V
    Eur J Neurol; 2021 Mar; 28(3):974-981. PubMed ID: 33340200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven day pre-analytical stability of serum and plasma neurofilament light chain.
    Altmann P; Ponleitner M; Rommer PS; Haslacher H; Mucher P; Leutmezer F; Petzold A; Wotawa C; Lanzenberger R; Berger T; Zetterberg H; Bsteh G
    Sci Rep; 2021 May; 11(1):11034. PubMed ID: 34040118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1).
    Nicoletti TF; Rossi S; Vita MG; Perna A; Guerrera G; Lino F; Iacovelli C; Di Natale D; Modoni A; Battistini L; Silvestri G
    J Neurol; 2022 Sep; 269(9):5085-5092. PubMed ID: 35575811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
    Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
    Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders.
    Dinoto A; Marcuzzo E; Chiodega V; Dall'Ora F; Mariotto S; Tinazzi M
    J Neurol; 2023 Mar; 270(3):1754-1758. PubMed ID: 36370187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood neurofilament light chain in Parkinson's disease.
    Buhmann C; Magnus T; Choe CU
    J Neural Transm (Vienna); 2023 Jun; 130(6):755-762. PubMed ID: 37067597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
    Eratne D; Janelidze S; Malpas CB; Loi S; Walterfang M; Merritt A; Diouf I; Blennow K; Zetterberg H; Cilia B; Wannan C; Bousman C; Everall I; Zalesky A; Jayaram M; Thomas N; Berkovic SF; Hansson O; Velakoulis D; Pantelis C; Santillo A;
    Aust N Z J Psychiatry; 2022 Oct; 56(10):1295-1305. PubMed ID: 35179048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.
    Götze K; Vrillon A; Bouaziz-Amar E; Mouton-Liger F; Hugon J; Martinet M; Dumurgier J; Cognat E; Zetterberg H; Blennow K; Hourrègue C; Paquet C; Lilamand M
    Neurobiol Dis; 2023 Jan; 176():105937. PubMed ID: 36462720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.